Table 5.
Comparison of response rate and topic subject matter
| RR | RR by CSSANZ | CSSANZ respondents (surveys sent) | RR overall | Overall respondents (total surveys sent) | Survey year | Study (publication year) | Survey topica | Survey type | Focus subject matter |
|---|---|---|---|---|---|---|---|---|---|
| Low RR | 7.3% | 12 (165) | ND | 1,064 (-) | 2012 | Holt et al. [13] (2017) | IBD diagnosis and Evaluation | CP, KSA | Attitudes of patients and clinicians about the role of diet and body weight in IBD. |
| 18.2% | 12 (66) | 67.3% | 33 (49) | 2009 | Spigelman et al. [2] (2013) | Preoperative assessment of colorectal patients | RP | Referral pathways of patients with newly diagnosed colorectal cancer sent to surgeons. | |
| 27.66% | 52 (188) | 3.4% | 72 (2100) | 2017 | Chittleborough et al. [21] (2018) | Endoscopy | CP, KSA | Quality in colonoscopic surveillance. | |
| 36.0% | 46 (128) | 49.0% | 264 (539) | 2010 | Leong et al. [6] (2015) | IBD diagnosis and evaluation | CP, KSA | Dysplasia screening and surveillance in IBD: knowledge and predictors of practice. | |
| 42.9% | 66 (154) | 42.9% | 66 (154) | 2011 | Behrenbruch et al. [10] (2015) | Rectal cancer decision-making | CP, DM | Consensus for treatment (decision-making and management) of rectal cancer patients with complete clinical response to neoadjuvant chemotherapy. | |
| 45.6% | 73 (160*) | ND | 181 (-) | 2015 | Chen et al. [18] (2017) | Colorectal neoplasm: screening and surveillance after polypectomy | CP, KSA | Study of clinicians’ attitudes towards the use of aspirin as a risk-reducing medication specifically in people at high risk for cancer due to an inherited cancer syndrome (Lynch syndrome) with no personal history of colorectal cancer (i.e., mutation carriers). | |
| High RR | 49.5% | 99 (200) | 50.0% | 118 (236) | 2015 | Jaung et al. [17] (2016) | Diverticular disease | CP | Current practices in the management of acute diverticulitis in Australasia. |
| 49.8% | 102 (205) | 49.8% | 102 (205) | 2016 | Siddiqui et al. [20] (2017) | Diverticular disease | CP, KSA | Correlation of current practices in management of diverticulitis with recent guidelines. | |
| 53.9% | 82 (152) | 53.9% | 82 (152) | 2010 | Kahokehr et al. [5] (2011) | Surgical management of colon cancer | CP | Current state and perceived barriers of perioperative colorectal practice in Australia and New Zealand. | |
| 58.4% | 111 (190) | 27.6% | 216 (782) | 2014 | Burnett et al. [16] (2018) | Pilonidal disease | CP, DM | Pilonidal sinus disease. | |
| 60.3% | 114 (189) | 60.3% | 114 (189) | 2010 | Warrier et al. [9] (2013) | Colon cancer: preoperative evaluation and staging | CP, DM | Clinical practice assessment regarding management of colorectal cancer in younger patients. | |
| 62.1% | 108 (174) | 62.1% | 108 (174) | 2010 | Ooi et al. [7] (2012) | Anal physiology: continence and defaecation | CP, DM | The management of rectal cancer by colorectal surgeons using MRI for locally advanced disease. | |
| 62.4% | 126 (202) | 62.4% | 126 (202) | 2015 | Zahid et al. [19] (2017) | Anal physiology: continence and defaecation | CP, DM | Surgical decision-making in the management of rectal prolapse. | |
| 62.7% | 128 (204) | 62.7% | 128 (204) | 2012 | Smart et al. [12] (2013) | Preoperative ssessment of colorectal patients | CP, KSA | Examining risk profiles for thromboembolic disease in colorectal cancer patients: comparison of guidelines and current practices. | |
| 64.2% | 106 (165) | 64.2% | 106 (165) | 2013 | Ansari et al. [15] (2015) | Rectal cancer: neoadjuvant therapy | CP, DM, KSA | Decision-making and certainty in the use of radiotherapy as neoadjuvant treatment in rectal cancer. | |
| 64.9% | 96 (148) | 64.9% | 96 (148) | 2010 | Suen et al. [8] (2015) | Large bowel obstruction | CP, DM | Self-expanding metallic stents for the management of large bowel obstruction: surgeon survey and review of barriers to conducting randomized controlled trials. | |
| 68.5% | 113 (165) | 68.5% | 113 (165) | 2012 | Al-Mozany et al. [14] (2017) | Anal physiology: continence and defaecation | CP, KSA | Barriers to management of obstructed defecation in Australia and New Zealand. | |
| 69.9% | 102 (146) | 69.9% | 102 (146) | 2009 | Jorgensen et al. [3] (2011) | Colorectal cancer: postoperative adjuvant therapy | CP, KSA | Older patients and adjuvant therapy for colorectal cancer: surgeon knowledge, opinions, and practices. | |
| 70.4% | 107 (152) | 70.4% | 107 (152) | 2011 | Hong et al. [11] (2014) | Rectal cancer: neoadjuvant therapy | CP, DM | Decision-making in the use of radiotherapy for patients with rectal cancer; perception of hierarchy of variables. | |
| 75.3% | 110 (146) | 75.3% | 110 (146) | 2009 | MacDermid et al. [4] (2014) | Anastomotic complications | DM | Decision-making with defunctioning stomas and rectal anastomoses. |
RR, response rate; CSSANZ, Colorectal Surgery Society Australia and New Zealand; RP, referral pathways; CP, current practices; DM, decision-making; KSA, knowledge and skills assessment; IBD, inflammatory bowel disease; MRI, magnetic resonance imaging; ND, not defined.
a
Based on Table of Contents of ASCRS Textbook of Colon and Rectal Surgery. 3rd ed. 2016 [1].